Terminal Respiratory Oxidases: A Targetables Vulnerability of Mycobacterial Bioenergetics?

Recently, ATP synthase inhibitor Bedaquiline was approved for the treatment of multi-drug resistant tuberculosis emphasizing the importance of oxidative phosphorylation for the survival of mycobacteria. ATP synthesis is primarily dependent on the generation of proton motive force through the electro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajeli, Sapna, Baid, Navin, Kaur, Manjot, Pawar, Ganesh P., Chaudhari, Vinod D., Kumar, Ashwani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719681/
https://www.ncbi.nlm.nih.gov/pubmed/33330134
http://dx.doi.org/10.3389/fcimb.2020.589318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719681/
https://www.ncbi.nlm.nih.gov/pubmed/33330134
http://dx.doi.org/10.3389/fcimb.2020.589318

Ejemplares similares